Drug Shortage Report for TARO-RISPERIDONE

Last updated on 2021-06-16 History
Report ID 132976
Drug Identification Number 02328372
Brand name RAN-RISPERIDONE
Common or Proper name RAN-RISPERIDONE
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) RISPERIDONE
Strength(s) 4.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-03
Estimated end date 2021-04-30
Actual end date 2021-05-04
Shortage status Resolved
Updated date 2021-06-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-06-16 French Compare
v7 2021-06-16 English Compare
v6 2021-05-01 French Compare
v5 2021-05-01 English Compare
v4 2021-02-14 French Compare
v3 2021-02-14 English Compare
v2 2021-01-31 French Compare
v1 2021-01-31 English Compare

Showing 1 to 8 of 8